Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022
-
AstraZeneca announces sale of its West Chester, Ohio (US) manufacturing site
-
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
-
AstraZeneca aims to redefine breast cancer care with new data across the treatment spectrum at SABCS 2022
-
AstraZeneca ranked in top three in the Access to Medicine Index
-
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer
-
Imfinzi plus chemotherapy recommended for approval in the EU by CHMP as first immunotherapy regimen for advanced biliary tract cancer
-
Lynparza in combination with abiraterone recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic castration-resistant prostate cancer
-
AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients in China
-
Imfinzi and Imjudo with chemotherapy approved in the US for patients with metastatic non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
